Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01615835 · ClinicalTrials.gov registry record · NA
EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant
A NA study of Congestive Heart Failure, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 2
- Study locations
NCT01615835: Completed NA study of Congestive Heart Failure, sponsored by Abbott Medical Devices.
NCT01615835 is a NA study of Congestive Heart Failure that has completed, run by Abbott Medical Devices. The registered enrollment target is 16 participants, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01615835, a NA study of Congestive Heart Failure, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 2
- Study locations
Study Summary
Use of the EnSite NavX system to map the coronary vasculature during CRT implant
Conditions Studied
Interventions
- OTHER EnSite NavX System
Study Locations (2)
Georgia
- Medical College of Georgia - Augusta
North Carolina
- Duke Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2007-04 |
| Est. Completion | 2007-10 |
| Phase | NA |
What the finished NCT01615835 record still lists
NCT01615835 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which EnSite NavX System is the first listed.
NCT01615835 reports a single indexed study location in Georgia, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01615835 about?
NCT01615835 is a clinical study titled "EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant". Use of the EnSite NavX system to map the coronary vasculature during CRT implant
What is the current status of trial NCT01615835?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2007-04. Estimated completion is 2007-10.
What conditions does trial NCT01615835 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT01615835?
The interventions under investigation include: EnSite NavX System (OTHER).
Who is sponsoring clinical trial NCT01615835?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01615835 being conducted?
This trial has 2 study locations across Georgia, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01615835's enrollment target sits among peer trials
16 49th of 51 higher than 3 of 51 other Congestive Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
SyncAV Post-Market Trial
ACTIVE NOT RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia